Molecule intelOpportunity: ModerateEssential

Progesterone

16 brands · 11 companies · product forms

ATC: G03DA04

Opportunity snapshot

Launch attractiveness
44
Market saturation
29
Price room
80
Regulatory risk
0
16
brands
11
companies
Rs 2,162.2
median price
9
price points
4.21x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 19%

Price room

Across observed sources and strengths
CheapestRs 770.67
MedianRs 2,162.2
Most expensiveRs 3,243.29
Spread4.21×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.21x across 9 trusted points (Rs 770.67-3243.29). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 10 live products for Progesterone — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(80) + 20% low-competition(71) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

11 canonical companies and 16 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.21x across 9 trusted points (Rs 770.67-3243.29). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.